BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 10981748)

  • 1. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
    Goodman JH; Yang W; Barth RF; Gao Z; Boesel CP; Staubus AE; Gupta N; Gahbauer RA; Adams DM; Gibson CR; Ferketich AK; Moeschberger ML; Soloway AH; Carpenter DE; Albertson BJ; Bauer WF; Zhang MZ; Wang CC
    Neurosurgery; 2000 Sep; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma.
    Kageji T; Nagahiro S; Kitamura K; Nakagawa Y; Hatanaka H; Haritz D; Grochulla F; Haselsberger K; Gabel D
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):120-30. PubMed ID: 11516861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma.
    Haselsberger K; Radner H; Pendl G
    Neurosurgery; 1996 Aug; 39(2):321-5; discussion 325-6. PubMed ID: 8832669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
    Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT).
    Haritz D; Gabel D; Huiskamp R
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1175-81. PubMed ID: 8175403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boron neutron capture therapy of brain tumors: functional and neuropathologic effects of blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Yang W; Barth RF; Rotaru JH; Boesel CP; Wilkie DA; Bresnahan JC; Hadjiconstantinou M; Goettl VM; Joel DD; Nawrocky MM
    J Neurooncol; 2000 Jul; 48(3):179-90. PubMed ID: 11100816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of sodium borocaptate: a critical assessment of dosing paradigms for boron neutron capture therapy.
    Gibson CR; Staubus AE; Barth RF; Yang W; Ferketich AK; Moeschberger MM
    J Neurooncol; 2003; 62(1-2):157-69. PubMed ID: 12749711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy.
    Kageji T; Nagahiro S; Otersen B; Gabel D; Nakaichi M; Nakagawa Y
    J Neurooncol; 2002 Sep; 59(2):135-42. PubMed ID: 12241106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model.
    Ceberg CP; Brun A; Kahl SB; Koo MS; Persson BR; Salford LG
    J Neurosurg; 1995 Jul; 83(1):86-92. PubMed ID: 7782856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
    Gregoire V; Begg AC; Huiskamp R; Verrijk R; Bartelink H
    Radiother Oncol; 1993 Apr; 27(1):46-54. PubMed ID: 8327732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution of boron in dogs with spontaneous intracranial tumors following borocaptate sodium administration.
    Kraft SL; Gavin PR; Leathers CW; DeHaan CE; Bauer WF; Miller DL; Dorn RV; Griebenow ML
    Cancer Res; 1994 Mar; 54(5):1259-63. PubMed ID: 8118814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of boron concentrations in blood from patients on boron neutron capture therapy.
    Shibata Y; Matsumura A; Yamamoto T; Akutsu H; Yasuda S; Nakai K; Nose T; Yamamoto K; Kumada H; Hori N; Ohtake S
    Anticancer Res; 2003; 23(6D):5231-5. PubMed ID: 14981995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors.
    Kageji T; Nakagawa Y; Kitamura K; Matsumoto K; Hatanaka H
    J Neurooncol; 1997 May; 33(1-2):117-30. PubMed ID: 9151229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition and tissue distribution of boron after infusion of borocaptate sodium in patients with malignant brain tumors.
    Horn V; Slánský J; Janku I; Strouf O; Sourek K; Tovarys F
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):631-8. PubMed ID: 9635713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
    Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Asano T; Kirihata M; Ono K; Kuroiwa T
    J Neurooncol; 2006 Jul; 78(3):227-32. PubMed ID: 16557351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors.
    Stragliotto G; Fankhauser H
    Neurosurgery; 1995 Feb; 36(2):285-92; discussion 292-3. PubMed ID: 7731508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium.
    Morris GM; Coderre JA; Hopewell JW; Micca PL; Rezvani M
    Radiother Oncol; 1994 Aug; 32(2):144-53. PubMed ID: 7972908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.